NBTX Nanobiotix - ADR
420
$6.90
$0.49
(7.64%)
| Watchers | 420 |
| 52-Wk Low | $4.55 |
| 52-Wk High | $11.00 |
| Market Cap | $325.07M |
| Volume | 24,199.00 |
| 52-Wk High | $11.00 |
| 52-Wk Low | $4.55 |
Nanobiotix to Present at Upcoming Investor Conferences in MarchGlobe Newswire • 2 months ago
PARIS and CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO NASDAQ: NBTX the ''Company''), a late-clinical stage biotechnology company pioneering physics-based...
Share to Feed
For the last three days, A.I.dvisor has detected that NBTX's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
For the last three days, A.I.dvisor has detected that NBTX's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
This is a signal that NBTX's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
This is a signal that NBTX's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
This indicator may be signaling that NBTX's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
In trading on Tuesday, shares of Nanobiotix SA (NBTX) crossed below their 200 day moving average of 6.88, changing hands as low as 6.23 per share. Nanobiotix SA shares are currently...
PARIS and CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO NASDAQ: NBTX the ''Company''), a late-clinical stage biotechnology company pioneering physics-based...
PARIS and CAMBRIDGE, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO NASDAQ: NBTX the ''Company''), a late-clinical stage biotechnology company pioneering physics-based...
This indicator may be signaling that NBTX's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...